Rare diseases
Investigational molecules
Locations
13203 Murphy Road, 77477-4303, United States
Immatics US Inc. focuses on solid tumors, with clinical research centered on T-cell–based immunotherapy for advanced malignancies. Its programs reflect a strong interest in tumor-directed treatments for patients with difficult-to-treat cancers.
The sponsor’s work in this area includes therapies designed to target cancer cells while addressing the needs of previously treated disease.
Immatics US Inc. runs clinical trials in conditions such as Neoplasm, Malignant melanoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
France
GermanyGermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
